Vincerx Pharma (VINC) Earnings Date & Reports

Get AI intraday signals

A.I. Advisor

published Earnings

VINC is expected to report earnings to fall 19.59% to -13 cents per share on April 01

Vincerx Pharma VINC Stock Earnings Reports

Q4'24

Est.

$-0.14

Q3'24

Beat

by $0.05

Q2'24

Beat

by $0.16

Q1'24

Missed

by $0.34

Q4'23

Beat

by $0.14

The last earnings report on November 12 showed earnings per share of -17 cents, beating the estimate of -21 cents. With 560.20K shares outstanding, the current market capitalization sits at 6.46M.

View a ticker or compare two or three

Compare

VINC

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For VINC
(Try 14 days for Free)

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

a blank check company, which was formed for the purpose of entering into a merger, share exchange, asset acquisition, stock purchase, recapitalization, and reorganization

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

260 Sheridan Avenue

Phone

+1 650 800-6676

Employees

Web

https://www.vincerx.com